Patents by Inventor Joel R. Walker

Joel R. Walker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzoimidazole Derivatives and Glycogen Synthase Kinase-3 Beta Inhibitors Containing the Same
    Publication number: 20110190351
    Abstract: Benzoimidazole Derivatives are provided. The compounds of the present invention are useful for Glycogen Synthase Kinase-3 Beta Inhibitors.
    Type: Application
    Filed: July 30, 2009
    Publication date: August 4, 2011
    Applicant: Oncotherapy Science, Inc.
    Inventors: Mitsuaki Ohtani, Yo Matsuo, Yingfu Li, Joel R. Walker, David M. Jenkins, Feryan Ahmed, Ryuji Ohsawa, Shoji Hisada
  • NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF
    Publication number: 20100152450
    Abstract: The invention relates to pyridinyl nicotinic acetylcholine receptor ligands, compositions comprising an effective amount of a pyridinyl nicotinic acetylcholine receptor ligand and methods to treat or prevent a condition, such as depression and nicotine dependence, comprising administering to an animal in need thereof an effective amount of a pyridinyl nicotinic acetylcholine receptor ligand.
    Type: Application
    Filed: October 13, 2009
    Publication date: June 17, 2010
    Applicants: PSYCHOGENICS, INC., The Board of Trustees of the University of Illinois
    Inventors: Jayaraman Chandrasekhar, Alan P. Kozikowski, Jianhua Liu, Werner Tueckmantel, Joel R. Walker, Po-wai Yuen
  • C-LINKED GLUCURONIDE OF N-(4-HYDROXYBENZYL) RETINONE, ANALOGS THEREOF, AND METHOD OF USING THE SAME TO INHIBIT NEOPLASTIC CELL GROWTH
    Publication number: 20090215706
    Abstract: Compounds of the formula: are described, along with pharmaceutical compositions containing these compounds, and methods of using the compounds to prevent and to treat cancer in mammals, including humans.
    Type: Application
    Filed: January 22, 2009
    Publication date: August 27, 2009
    Inventors: Margaret Clagett-Dame, Robert W. Curley, JR., Joel R. Walker, Hussein Abou-Issa, Galal A. Alshafie
  • C-linked glucuronide of -(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth
    Patent number: 7528114
    Abstract: Compounds of the formula: are described, along with pharmaceutical compositions containing these compounds, and methods of using the compounds to prevent and to treat cancer in mammals, including humans.
    Type: Grant
    Filed: May 3, 2006
    Date of Patent: May 5, 2009
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Margaret Clagett-Dame, Robert W. Curley, Jr., Joel R. Walker, Hussein Abou-Issa, Galal A. Alshafie